Topological properties of the drug targets regulated by microRNA in human protein–protein interaction network

References

• Aittokallio T, Schwikowski B. (2006). Graph-based methods for analysing networks in cell biology. Brief Bioinformatics, 7, 243–255.
   PubMed Web of Science ®Google Scholar
• Ambros V. (2004). The functions of animal microRNAs. Nature, 431, 350–355.
   PubMed Web of Science ®Google Scholar
• Betel D, Wilson M, Gabow A, Marks DS, Sander C. (2008). The microRNA.org resource: targets and expression. Nucleic Acids Res, 36, D149–D153.
   PubMed Web of Science ®Google Scholar
• Borgatti SP, Everett MG. (2006). A Graph-theoretic perspective on centrality. Soc Netw, 28, 466–484.
   Web of Science ®Google Scholar
• Bu D, Zhao Y, Cai L, Xue H, Zhu X, Lu H, Zhang J, Sun S, Ling L, Zhang N, Li G, Chen R. (2003). Topological structure analysis of the protein-protein interaction network in budding yeast. Nucleic Acids Res, 31, 2443–2450.
   PubMed Web of Science ®Google Scholar
• Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA, 102, 13944–13949.
   PubMed Web of Science ®Google Scholar
• Cusick ME, Klitgord N, Vidal M, Hill DE. (2005). Interactome: gateway into systems biology. Hum Mol Genet, 14(Spec No. 2), R171–R181.
   PubMedGoogle Scholar
• Debernardi S, Skoulakis S, Molloy G, Chaplin T, Dixon-McIver A, Young BD. (2007). MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia, 21, 912–916.
   PubMed Web of Science ®Google Scholar
• Sonkolya E, Ståhlea M, Pivarcsi A. (2008). MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol, 18, 131–140.
   PubMed Web of Science ®Google Scholar
• Fraser HB, Hirsh AE, Steinmetz LM, Scharfe C, Feldman MW. (2002). Evolutionary rate in the protein interaction network. Science 296, 750–752.
   PubMed Web of Science ®Google Scholar
• Garofalo M, Condorelli G, Croce CM. (2008). MicroRNAs in diseases and drug response. Curr Opin Pharmacol, 8, 661–667.
   Google Scholar
• Kar G, Gursoy A, Keskin O. (2009). Human cancer protein-protein interaction network: a structural perspective. PLoS Comput Biol, 5, e1000601.
   PubMed Web of Science ®Google Scholar
• Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, Jonsson E, Andreassen OA, Djurovic S, Melle I, Agartz I, Hall H, Timm S, Wang AG, Werge T. (2007). Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE, 2, e873.
   PubMed Web of Science ®Google Scholar
• Hopkins AL. (2008). Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol, 4, 682–690.
   PubMed Web of Science ®Google Scholar
• Hsu CW, Juan HF, Huang HC. (2008). Characterization of microRNA-regulated protein-protein interaction network. Proteomics, 8, 1975–1979.
   PubMed Web of Science ®Google Scholar
• Janssen JJ, Klaver SM, Waisfisz Q, Pasterkamp G, de Kleijn DP, Schuurhuis GJ, Ossenkoppele GJ. (2005). Identification of genes potentially involved in disease transformation of CML. Leukemia, 19, 998–1004.
   PubMed Web of Science ®Google Scholar
• Joy MP, Brock A, Ingber DE, Huang S. (2005). High-betweenness proteins in the yeast protein interaction network. J Biomed Biotechnol, 2, 96–103.
   Google Scholar
• Leicht, DT, Balan V, Kaplun A, Singh-Gupta V, Kaplun L, Dobson M, Tzivion G. (2007). Raf kinases: function, regulation and role in human cancer. Biochim Biophys Acta, 1773, 1196–1212.
   PubMed Web of Science ®Google Scholar
• Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, Braich R, Manoharan M, Soutschek J, Skare P, Klein LO, Davis MM, Chen CZ. (2007). miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell, 129, 147–161.
   PubMed Web of Science ®Google Scholar
• Liang H, Li WH. (2007). MicroRNA regulation of human protein protein interaction network. RNA, 13, 1402–1408.
   PubMed Web of Science ®Google Scholar
• Loging W, Harland L, Williams-Jones B. (2007). High-throughput electronic biology: mining information for drug discovery. Nat Rev Drug Discov, 6, 220–230.
   PubMed Web of Science ®Google Scholar
• Ma’ayan A, Jenkins SL, Goldfarb J, Iyengar R. (2007). Network analysis of FDA approved drugs and their targets. Mt Sinai J Med, 74, 27–32.
   PubMed Web of Science ®Google Scholar
• Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG. (2007). miRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res, 35, D149–D155.
   PubMed Web of Science ®Google Scholar
• Mishra GR, Suresh M, Kumaran K, Kannabiran N, Suresh S, Bala P, Shivakumar K, Anuradha N, Reddy R, Raghavan TM, Menon S, Hanumanthu G, Gupta M, Upendran S, Gupta S, Mahesh M, Jacob B, Mathew P, Chatterjee P, Arun KS, Sharma S, Chandrika KN, Deshpande N, Palvankar K, Raghavnath R, Krishnakanth R, Karathia H, Rekha B, Nayak R, Vishnupriya G, Kumar HG, Nagini M, Kumar GS, Jose R, Deepthi P, Mohan SS, Gandhi TK, Harsha HC, Deshpande KS, Sarker M, Prasad TS, Pandey A. (2006). Human protein reference database–2006 update. Nucleic Acids Res, 34, D411–D414.
   PubMed Web of Science ®Google Scholar
• Nacher JC, Schwartz JM. (2008). A global view of drug-therapy interactions. BMC Pharmacol, 8, 5.
   PubMedGoogle Scholar
• Overington JP, Al-Lazikani B, Hopkins AL. (2006). How many drug targets are there? Nat Rev Drug Discov, 5, 993–996.
   PubMed Web of Science ®Google Scholar
• Sakharkar MK, Li P, Zhong Z, Sakharkar KR. (2008). Quantitative analysis on the characteristics of targets with FDA approved drugs. Int J Biol Sci, 4, 15–22.
   Web of Science ®Google Scholar
• Sharan R, Ulitsky I, Shamir R. (2007). Network-based prediction of protein function. Mol Syst Biol, 3, 88.
   PubMed Web of Science ®Google Scholar
• Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. (2006). BioGRID: a general repository for interaction datasets. Nucleic Acids Res, 34, D535–D539.
   PubMed Web of Science ®Google Scholar
• Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, Timm J, Mintzlaff S, Abraham C, Bock N, Kietzmann S, Goedde A, Toksöz E, Droege A, Krobitsch S, Korn B, Birchmeier W, Lehrach H, Wanker EE. (2005). A human protein-protein interaction network: a resource for annotating the proteome. Cell, 122, 957–968.
   PubMed Web of Science ®Google Scholar
• Wang YY. (2009). Functional homogeneity in microRNA target heterogeneity. Genome Biol, submitted.
   Google Scholar
• Weiss GJ, Bemis LT, Nakajima E, Sugita M, Birks DK, Robinson WA, Varella-Garcia M, Bunn PA Jr, Haney J, Helfrich BA, Kato H, Hirsch FR, Franklin WA. (2008). EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann Oncol, 19, 1053–1059.
   PubMed Web of Science ®Google Scholar
• Wienholds E, Plasterk RH. (2005). MicroRNA function in animal development. FEBS Lett, 579, 5911–5922.
   PubMed Web of Science ®Google Scholar
• Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M. (2008). DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res, 36, D901–D906.
   PubMed Web of Science ®Google Scholar
• Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J. (2006). DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res, 34, D668– D672.
   PubMed Web of Science ®Google Scholar
• Yildirim MA, Goh KI, Cusick ME, Barabási AL, Vidal M. (2007). Drug-target network. Nat Biotechnol, 25, 1119–1126.
   PubMed Web of Science ®Google Scholar
• Yu H, Kim PM, Sprecher E, Trifonov V, Gerstein M. (2007). The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput Biol, 3, e59.
   PubMed Web of Science ®Google Scholar
• Zhu M, Gao L, Li X, Liu Z, Xu C, Yan Y, Walker E, Jiang W, Su B, Chen X, Lin H. (2009). The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network. J Drug Target, 17, 524–532.
   PubMed Web of Science ®Google Scholar